Delivery Order SPE2DB22D2006-SPE2DB25FW0JC
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,560.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Exforge 5-160 mg tablets, a medication used to treat high blood pressure. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award, with the ID SPE2DB20D2104|SPE2DB25FMELL, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566759953 Exforge 5-160 mg tablet 30s, with a firm fixed price of $1,835.55 and a completion date of December 19, 2024. The contract is a delivery order type, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor,...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,058.36, is for the delivery of Exforge 5-320 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of March 17, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB24D2101|SPE2DB24FKGQM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Exforge 5-160 mg tablet in 30-count packages. The contract has a total ceiling value of $4,466.29 and is a Firm Fixed Price delivery order, with a final completion date of September 19, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award, which does not have a set-aside...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Exforge 5-160 mg tablets. The $2,797.79 firm fixed-price contract has a period of performance through February 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,242.94, is for the delivery of Exforge 5-160 mg tablets. It is a delivery order contract with a firm fixed price pricing type and has a completion date of May 2, 2023. The award does not have a set-aside designation, indicating it was awarded through full and open competition....
This federal contract award, with ID SPE2DB22D2009|SPE2DB24FM0YE, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,481.36 firm fixed-price contract is for the delivery of Exforge 10-320 mg tablets. The contract is not designated under any set-aside program. It is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award, valued at $2,448.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is a delivery order contract for Exforge 5-160 mg tablets, which are likely pharmaceutical products used to treat various medical conditions. The contract has an ultimate completion date of December 19, 2024, and it is a firm-fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, valued at $15,002.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award...
This is a federal contract award to AmerisourceBergen Drug Corp for the delivery of Exforge 5-320 MG Tablets in quantities of 30s. The contract, valued at $1,307.80, was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of January 15, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...